Metropolitan Life Insurance Company (MetLife)’s Strata Critical Medical Inc SRTA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,048	Closed	-$2.99K	–	299
2024 Q1	$2.99K	Sell	1,048 -2,536	-71%	-$7.82K	﹤0.01%	2277
2023 Q4	$12.7K	Hold	3,584	–	–	﹤0.01%	2100
2023 Q3	$9.28K	Hold	3,584	–	–	﹤0.01%	2240
2023 Q2	$14.1K	Buy	3,584 +1,948	+119%	+$6.18K	﹤0.01%	2113
2023 Q1	$5.53K	Sell	1,636 -2,118	-56%	-$8.64K	﹤0.01%	2269
2022 Q4	$13.4K	Hold	3,754	–	–	﹤0.01%	2177
2022 Q3	$15.1K	Hold	3,754	–	–	﹤0.01%	2153
2022 Q2	$16.7K	Buy	+3,754	New	+$27.1K	﹤0.01%	2125

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SRTA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Strata Critical Medical Inc (SRTA) in Q2 2024, closing a stake of 1,048 shares — an estimated $2.99K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SRTA in Q2 2022 and held it in 8 quarters. The position peaked at $16.7K in Q2 2022. 117 funds tracked by Wall St. Rank hold SRTA as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Strata Critical Medical Inc position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,048 Strata Critical Medical Inc shares in Q2 2024, an estimated $2.99K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Strata Critical Medical Inc position peaked at $16.7K in Q2 2022.
117 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.